Weight Loss Information
Thank you for booking with The Clybaun Clinic!
Knowledge is POWER so let us explain your treatment in full
This is your information pack. We ask that you read this before attending your treatment and keep it as it contains information you may need later.
In order to help you reach your goal weight we will provide you with prescription weight loss medication (provided you meet the criteria), you will attend once month for a review when getting your repeat prescription and we are very proud to offer access to our weight loss community where you will find information on gyms, exercise classes, group meet ups (exercise and foodie days), share tips and recipe’s and have access to our personal trainers who can help you with meal planning or custom work outs. We know weight loss can be a hard road but we aim to make it fun by meeting new like minded friends and keeping your diet exciting.
To the left you can scroll through the photos and see some before and after pictures of prescription weight loss. If you scroll down you will find all the information on your treatment, before care, after care, frequently asked questions, manufactures information and our clinic terms and conditions.
Finance options coming soon. Please see our packages pages to see if you could save money by combining treatments
WHY YOU SHOULD TRUST US
Our medical weight loss practitioners have completed intense training provided by The National Weight Loss Programme. The programme is taught by a Dr Matt Capehorn who has run the largest Obesity Clinic in the United Kingdom for over 12 years. He has also been involved in a very large number of studies on obesity and sits as an advisor on multiple obesity council boards. Having the input of Dr Capehorn provides our clients with an unparalleled support and knowledge base during their weight loss journey. Furthermore, the programme is based on hundreds of years of research and hard facts, endorsed by the National Institute of Clinical Excellence and supported by the Royal College of Nursing, so that we can answer any questions you might have and back them up with the science behind them.
WHAT IS ? Prescription Weight Loss?
Prescription weight loss has been used for many decades but we never really cracked the code on how to do it safely… until now. We are delighted to bring Ozempic’s and Saxenda’s revolutionary prescription weight loss products to our clients. We are sure by now you will have heard about them all over the news, Hollywoods best kept secret now revealed and now available to you. You are invited to attend a consultation where you will meet with a medical weight loss expert who will do a number of tests (measurement of your waist circumference, weight, height, blood glucose and medical history) to determine your suitability for the medication.
How does it Work?
Your body produces two hormones, Ghrelin (the gremlin) which causes hunger and Leptin which makes you feel full. Your medication works on the GLP-1 protein which increase your Leptin making your feel fuller for longer, stimulates your insulin production making your cells absorb sugars giving you more energy and slows your stomach emptying time.
Used to Treat
This prescription weight loss is used to treat people of larger waist circumferences or body mass index’s. Women with a waist circumference greater than 88cm and men with a waist circumference greater than 102cm are at much higher risk of diseases such as Diabetes, Heart Failure, COPD and Cancer. There are over 300 disease’s and 13 different Cancers directly related to obesity. But the good news is you can decrease your risk of dying by up to 50% if you loose 10kg of body fat and we are here to insure your optimal health. Indirectly new research is showing that weight loss medications are also helping fight anxiety and depression, they have even been shown to help with a range of addictions: sugar, food, alcohol etc.
How Long will it Last?
Your Saxenda medication is a daily injection and your Ozempic medication is a weekly injection. We will usually try to prescribe you Ozempic, if you fit the criteria, but because of its unparalleled success there is a world wide shortage of the drug, we however have a fantastic supplier and are proud to say we rarely run out. Sexanda will be out of your system in a day or two where as Ozempic can take some weeks before it is fully out of the body. For your convivence we generally provide a months supply of medication. Weight regain and length of time taking the drug will be further explained at consultation and in your information pack you will receive at your consultation.
What’s in the Information pack?
You will receive your information pack when you are deemed suitable for treatment and are given your medication. The pack includes a guide to how fat affects the body and how to recognise your risk of disease and reduce that risk, how weight is affected by sleep patterns, diet , recommended diets, understanding calories, intermittent fasting information, exercise, information on putting weight back on and how to avoid this, a guide to how your medication works and lots of tips throughout.
Does it Hurt?
A very fine diabetic needle is used and this treatment is not described as painful and can be tolerated well with no anaesthetic.
BEFORE YOUR APPOINTMENT
- Please be aware that you can not receive this medication if you –
- Aged under 18 or above 75
- Severe renal/kidney impairment (with eGFR of 50 or below) or a history of renal disease
- Severe hepatic/liver impairment
- Personal or family history of medullary thyroid cancer(MTC)
- Hypersensitivity to Ozempic/Saxenda or to any of the excipients: disodium phosphate dihydrate, propylene glycol, phenol and water for injection.
- Concurrent treatment with any other products for weight management
- Weight problems related to endocrinological or eating disorders
- Concurrent insulin or sulfonylurea
- Patients on warfarin (more frequent INR monitoring required)
- Concurrent use of any medicinal products with may cause weight gain
- Pregnancy, breastfeeding or trying to/planning to become pregnant.
- Congestive heart failure
- History of pancreatitis, gallbladder disease, inflammatory bowel disease, diabetic gastroparesis.
- If you have diabetes you will need to discuss the medication with your diabetic nurse before hand who we will also need to contact.
- Do cancel if you are at all unwell, even minor coughs and colds can increase your risk of post treatment complications.
- Please try not to drink any large amount of water before your appointment as this will change your weight.
- Please wear comfortable clothes where access to your waist can be had. We usually recommend you wear similar clothes each time to get a true weight reading.
- Do contact the clinic to discuss any illness or new medicines prior to attending.
TREATMENT AFTER CARE
So you have your prescription what now ?
Thank you for choosing the Clybaun Clinic to have your treatment with. We endeavor to assure you have an excellent experience from start to finish and this aftercare advice has been devised from the frequently asked Do`s and Don’t`s of post treatment. Please understand this advice is to ensure you achieve optimum results and by not following your aftercare advice your desired treatment effects may be affected and you may incur unwanted complications. Should you have any concerns please contact a member of the team.
AFTERCARE ADVICE
During your consultation you will be given an information pack containing everything you need for on going care. You will need to notify us one week before you prescription is due for renewal and come to the clinic once monthly for a review and to collect a repeat prescription. You will have on going support from professionals and new friends through our Facebook community but you are welcome to contact the clinic directly if you have any questions. When you start any new medication it is advised you start low and build up to avoid any side effects. If you start to experience side effects such as nausea, diarrhoea, constipation, vomiting, injection site reaction, low blood sugar (hypoglycaemia), headache, tiredness (fatigue), dizziness, stomach pain, and change in enzyme (lipase) levels in your blood you may need to reduce your dose.
Emergencies
All drugs carry risks. The most serious but rare risk is anaphylaxis (a severe allergic reaction) which in itself is life threatening and requires immediate medical attention. Clients have access to our 24 hour phone number (07809902432) should an emergency arise. However, as explained to you if you experience any shortness of breath, wheezing, coughing, difficulty speaking, swallowing, swelling of the tongue, eyelids, lips, hoarseness of the voice, stomach pain, nausea or diarrhea you should ring 999 immediately do not wait.
Manufactures Information
Saxenda
The main benefits may include:
1.Saxenda (Liraglutide) is 97% similar to natural human GLP-1 and therefore acts as a physiological regulator of appetite and thereby reducing food intake by reducing feelings of hunger and increasing feelings of fullness/satiety. The exact underlying mechanism of action is not entirely clear.
2.Saxenda(Liraglutide 3mg injection)is a newly licensed medication indicated for reduction in appetite as an adjunct to a reduced-calorie diet and increased physical activity for weight management of patients with an increased Body Mass Index (BMI).
3.For long term success the treatment needs to be combined with lifestyle changes including nutritional, excercise and behavioural habits. Access to support modules are given through the Weight Journey online service.
4.Weight loss can lead to secondary benefits by improving weight loss related health problems such as cardiovascular risk factors (including hypertension, blood glucose levels and waist circumference) and physical health-related Quality of Life.
You should understand that:
1.Alternatives to Saxenda therapy are surgical procedures, oral medical treatments (including Orlistat)and / or dietary and lifestyle changes alone.
2.Several weeks to months of treatment may be required depending on your individual response.
3.If a missed dose is more than 12 hours late, the missed dose should not be taken and the next dose should be taken at the normal time.
4.It is essential to combine eating, exercise and behavioral modifications with Saxenda.
5.Saxenda should not be used in combination with another GLP-1 receptor agonist, insulin or insulin secretagogues (such as sulfonylureas)due to the risk of hypoglycaemia.
6.Upon initiation of liraglutide treatment in patients on warfarin or other coumarin derivatives more frequent monitoring of International Normalised Ratio (INR) is recommended.
7.Saxenda® causes a delay of gastric emptying, and has the potential to impact the absorption of concomitantly administered oral medications. Monitor for potential consequences of delayed absorption of oral medications concomitantly administered with Saxenda®
8.There are several special warnings and precautions for use of Saxenda including warnings on pancreatitis, cholelithiasis and cholecystitis, thyroid disease, heart rate, dehydration and hypoglycaemia in people with type 2 diabetes.
9.Thyroid adverse events, such as goitre have been reported in particular in patients with pre-existing thyroid disease. Saxenda should therefore be used with caution in patients with thyroid disease.
10.A higher rate of cholelithiasis and cholecystitis(gallstone and gallbladder disease)has been observed in patients treated with liraglutide. Cholelithiasis and cholecystitis may lead to hospitalisation and cholecystectomy(surgery to remove the gallbladder). Patients should be aware of the characteristic symptoms of cholelithiasis and cholecystitis.
11.Signs and symptoms of dehydration, including renal impairment and acute renal failure, have been reported in patients treated with Liraglutide. Patients treated with liraglutide should be advised of the potential risk of dehydration in relation to gastrointestinal side effects and take precautions to avoid fluid depletion. Patients should also be aware of the symptoms of increased heart rate.
12.Acute pancreatitis has been observed with the use of Liraglutide. Patients and their carers should be told how to recognise signs and symptoms of acute pancreatitis and advised to seek immediate medical attention if symptoms develop. If pancreatitis is suspected, liraglutide should be discontinued; if acute pancreatitis is confirmed, liraglutide should not be restarted.
13.Liraglutide may cause dose-dependent and treatment-duration-dependent thyroid C-cell tumors at clinically relevant exposures in both genders of rats and mice. It is unknown whether Saxenda® causes thyroid C-cell tumors, including medullary thyroid carcinoma(cancer, MTC), in humans, as the human relevance of liraglutide-induced rodent thyroid C-cell tumors has not been determined. Patients should be aware of symptoms of thyroid tumours(such as a mass in the neck, difficulty swallowing, difficulty breathing or shortness of breath, persistent hoarseness).
Side Effects
please read full Patient information leaflet for most up to date information –
https://www.medicines.org.uk/emc/product/2313
Like all medicines, this medicine can cause side effects, although not everybody gets them.
Serious side effects
Some severe allergic reactions (anaphylaxis) have been reported rarely in patients using Saxenda®.
You should see your doctor straight away if you get symptoms such as breathing problems, swelling
of face and throat and a fast heartbeat.
Cases of inflammation of the pancreas (pancreatitis) have been reported uncommonly in patients using
Saxenda®. Pancreatitis is a serious, potentially life-threatening medical condition.
Stop taking Saxenda® and contact a doctor immediately if you notice any of the following serious
side effects:
• Severe and persistent pain in the abdomen (stomach area) which might reach through to your
back, as well as nausea and vomiting, as it could be a sign of an inflamed pancreas
(pancreatitis).
Other side effects
Very common: may affect more than 1 in 10 people
• Feeling sick (nausea), being sick (vomiting), diarrhoea, constipation, headache – these usually
go away after a few days or weeks.
Common: may affect up to 1 in 10 people
• Problems affecting the stomach and intestines, such as indigestion (dyspepsia), inflammation in
the lining of the stomach (gastritis), stomach discomfort, upper stomach pain, heartburn, feeling
bloated, wind (flatulence), belching and dry mouth
• Feeling weak or tired
• Changed sense of taste
• Dizziness
• Difficulty sleeping (insomnia). This usually occurs during the first 3 months of treatment
• Gallstones
• Injection site reactions (such as bruising, pain, irritation, itching and rash)
• Low blood sugar (hypoglycaemia). The warning signs of low blood sugar may come on
suddenly and can include: cold sweat, cool pale skin, headache, fast heartbeat, feeling sick,
feeling very hungry, changes in vision, feeling sleepy, feeling weak, being nervous, being
anxious, confusion, difficulty concentrating and shaking (tremor). Your doctor will tell you
how to treat low blood sugar and what to do if you notice these warning signs
• increase of pancreatic enzymes, such as lipase and amylase.
Uncommon: may affect up to 1 in 100 people
• Loss of fluids (dehydration). This is more likely to occur at the start of treatment and may be
due to being sick (vomiting), feeling sick (nausea) and diarrhoea
• Delay in the emptying of the stomach
• Inflamed gall bladder
• Allergic reactions including skin rash
• Feeling generally unwell
• Faster pulse.
Rare: may affect up to 1 in 1,000 people
• Reduced kidney function
• Acute kidney failure. Signs may include reduction in urine volume, metallic taste in mouth and
easily bruising.
Ozempic
The main benefits may include:
1.Ozempic (Semaglutide) is 94% similar to natural human GLP-1 and therefore acts as a physiological regulator of appetite and thereby reducing food intake by reducing feelings of hunger and increasing feelings of fullness/satiety. The exact underlying mechanism of action is not entirely clear.
2.Ozempicis a newly licensed medication indicated for the treatment of type-2 diabetes. It is currently undergoing clinical trial to gain a license for the treatment of obesity. In the mean time, your medical practitioner may prescribe this medication for you ‘off-label’
3.For long term success the treatment needs to be combined with lifestyle changes including nutritional, exercise and behavioural habits.
4.Weight loss can lead to secondary benefits by improving weight loss related health problems such as cardiovascular risk factors (including hypertension, blood glucose levels and waist circumference) and physical health-related Quality of Life.
You should understand that:
1.Alternatives to Ozempic therapy are surgical procedures, oral medical treatments(including Orlistat) and / or dietary and lifestyle changes alone.
2.Several weeks to months of treatment may be required depending on your individual response.
3.If a missed dose is more than 5 days late, the missed dose should not be taken, and the next dose should be taken at the normal time.
4.It is essential to combine eating, exercise and behavioural modifications with Ozempic.
5.Ozempic should not be used in combination with another GLP-1 receptor agonist, insulin or insulin secretagogues (such as sulfonylureas) due to the risk of hypoglycaemia.
6.Upon initiation of Ozempic treatment in patients on warfarin or other coumarin derivatives more frequent monitoring of International Normalised Ratio (INR) is recommended.
7.Ozempic causes a delay of gastric emptying and has the potential to impact the absorption of concomitantly administered oral medications. Monitor for potential consequences of delayed absorption of oral medications concomitantly administered with Ozempic A higher rate of cholelithiasis and cholecystitis (gallstone and gallbladder disease) has been observed in patients treated with semaglutide. Cholelithiasis and cholecystitis may lead to hospitalisation and cholecystectomy (surgery to remove the gallbladder). Patients should be aware of the characteristic symptoms of cholelithiasis and cholecystitis.
8.There are several special warnings and precautions with Ozempic including warnings on pancreatitis, chloelitious, cholecyctious, thyroid disease, heart rate, dehydration and hypoglycaemia in people with type 2 diabetes.
9.Thyroid adverse events, such as goitre have been reported in particular patients with pre-existing thyroid disease. Ozempic should therefore be used with caution in patients with thyroid disease.
10.thyroid disease. Ozempic should therefore be used with caution in patients with thyroid disease.9.Thyroid adverse events, such as goitre have been reported in particular in patients with pre-existing8.There are several special warnings and precautions for use of Ozempic including warnings on pancreatitis, cholelithiasis and cholecystitis, thyroid disease, heart rate, dehydration and hypoglycaemia in people with type 2 diabetes.
11.Signs and symptoms of dehydration, including renal impairment and acute renal failure, have been reported in patients treated with Semaglutide. Patients treated with semaglutide should be advised of the potential risk of dehydration in relation to gastrointestinal side effects and take precautions to avoid fluid depletion. Patients should also be aware of the symptoms of increased heartrate.
12.Acute pancreatitis has been observed with the use of Semaglutide. Patients and their carers should be told how to recognise signs and symptoms of acute pancreatitis and advised to seek immediate medical attention if symptoms develop. If pancreatitis is suspected, semaglutide should be discontinued; if acute pancreatitis is confirmed, semaglutide should not be restarted.
13.Ozempicmay cause dose-dependent and treatment-duration-dependent thyroid C-cell tumours at clinically relevant exposures in both genders of rats and mice. It is unknownwhetherOzempic causes thyroid C-celltumours, including medullary thyroid carcinoma (cancer, MTC), inhumans, as the human relevanceofsemaglutide-induced rodent thyroid C-celltumourshas notbeen determined. Patients should be aware of symptoms of thyroid tumours (such as a mass in theneck, difficulty swallowing, difficulty breathing or shortness of breath, persistent hoarseness).
Side Effects
(please read full Patient information leaflet for most up to date information –https://www.medicines.org.uk/emc/product/9750/pil)
Serious side effects
Common: may affect up to 1 in 10 peoplecomplications of diabetic eye disease (retinopathy) – you should inform your doctor if you experience eye problems, such as changes in vision, during treatment with this medicine.
Uncommon: may affect up to 1 in 100 peopleInflamed pancreas (acute pancreatitis) which could cause severe pain in the stomach and back which does not go away. You should see a doctor immediately if you experience such symptoms.
Rare: may affect up to 1 in 1,000 peoplesevere allergic reactions (anaphylactic reactions). You should seek immediate medicalhelp and inform your doctor straight away if you get symptoms suchas breathingproblems, swelling of face and throat and a fast heartbeat.
